Stephen R. Davis
2018
In 2018, Stephen R. Davis earned a total compensation of $6.5M as Chief Executive Officer at ACADIA Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $493,806 |
|---|---|
| Option Awards | $4,771,631 |
| Salary | $719,833 |
| Stock Awards | $505,400 |
| Other | $17,362 |
| Total | $6,508,032 |
Davis received $4.8M in option awards, accounting for 73% of the total pay in 2018.
Davis also received $493.8K in non-equity incentive plan, $719.8K in salary, $505.4K in stock awards and $17.4K in other compensation.
Rankings
In 2018, Stephen R. Davis' compensation ranked 1,394th out of 14,244 executives tracked by ExecPay. In other words, Davis earned more than 90.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,394 out of 14,244 | 90th |
Division Manufacturing | 484 out of 5,765 | 92nd |
Major group Chemicals And Allied Products | 151 out of 2,128 | 93rd |
Industry group Drugs | 118 out of 1,817 | 94th |
Industry Pharmaceutical Preparations | 86 out of 1,391 | 94th |
Source: SEC filing on April 30, 2021.
Davis' colleagues
We found three more compensation records of executives who worked with Stephen R. Davis at ACADIA Pharmaceuticals in 2018.